Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel vanadyl-catalyzed oxidation method for 6-hydroxy-2H-pyran-3-one. Mild conditions, high yield, scalable for pharmaceutical intermediates supply chain.
Novel patent CN104098556B offers high-yield Rivaroxaban intermediate synthesis. Reduces toxic reagents and simplifies purification for reliable supply chain partners.
Patent CN108329256B discloses a Pd-catalyzed one-pot synthesis of polysubstituted benzo[c,d]indoles. This method offers high yield, mild conditions, and scalable production for anticancer drug intermediates.
Novel iron complex catalyst enables high-yield hydrogenation for API intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN117702144A enables green electrocatalytic synthesis. Delivers high-purity pharmaceutical intermediates with reduced metal contamination and streamlined supply chain reliability.
Patent CN100509729C details a novel Grignard-based synthesis of resveratrol offering high yield and mild conditions, ensuring cost-effective supply chain solutions.
Novel aluminum catalyst enables anti-Markovnikov hydroamination with high yield. Reduces cost and improves supply chain reliability for amine synthesis.
Patent CN104557934A details efficient sophocarpine synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN108473451A reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel copper-catalyzed C-H activation method for 8-thiaxanthine compounds. High yield, scalable process for pharmaceutical intermediates like KW-6002.
Novel CBS-catalyzed synthesis ensures high ee value and yield. Scalable process for antiviral intermediate supply chain stability and cost efficiency.
Novel synthesis route for aPKC inhibitor intermediates ensures high purity and scalable production for pharmaceutical supply chains.
Patent CN107325122B reveals a streamlined synthesis for prostaglandin intermediates, offering significant cost reduction and enhanced safety for pharmaceutical manufacturing.
Patent CN106117129B reveals a green oxidation route for pyridoxal using bismuth tungstate. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel preparation method of Bosutinib avoiding hazardous chlorinating agents. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN105693719A details iron-catalyzed synthesis of 3,3-spiro indolones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104557887B reveals a novel 1,8-naphthalimide synthesis with significant antitumor activity. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN107759510B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN108794396A details efficient oxidation of 4-oxo-2,3-dihydroquinolines. Offers high yield, low cost, and scalable supply chain solutions for pharmaceutical intermediates.
Advanced synthesis of Belinostat intermediate II via safe esterification and HWE reactions. Reduces hazards and costs for HDAC inhibitor manufacturing.